Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 59, Number 6, September 24, 2002
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexandrov, A. V.
Right arrow Articles by Grotta, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexandrov, A. V.
Right arrow Articles by Grotta, J. C.
Related Collections
Right arrow All Clinical trials
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction

Neurology 2002;59:862-867
© 2002 American Academy of Neurology

Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator

Andrei V. Alexandrov, MD and James C. Grotta, MD

From the Stroke Treatment Team, University of Texas–Houston Medical School, Houston, TX.

Address correspondence and reprint requests to Dr. A.V. Alexandrov, MSB 7.044, 6431 Fannin St., University of Texas, Houston, TX 77030; e-mail: avalexandrov{at}att.net

Background: Arterial reocclusion has not been systematically studied despite the fact that 13% of patients in the National Institute of Neurological Diseases and Stroke rt-PA Trial deteriorated following initial improvement, suggesting that reocclusion might be responsible for poor clinical outcome in some of these patients.

Methods: Consecutive stroke patients treated with IV tissue plasminogen activator (TPA) within 3 hours and an M1 or M2 middle cerebral artery (MCA) occlusion on pre-TPA transcranial Doppler (TCD) were monitored up to 2 hours after TPA bolus. Reocclusion was defined as the Thrombolysis in Brain Ischemia flow decrease by >=1 grades and no hemorrhage on repeat CT. The NIH Stroke Scale (NIHSS) and modified Rankin Scores (mRS) were obtained by a neurologist independently of TCD.

Results: Sixty patients with median prebolus NIHSS score of 16 (range 6 to 28, 90% with >=10 points) had TPA bolus at 130 ± 32 minutes (median 120 minutes, 58% within the first 2 hours). Recanalization was complete in 18 (30%), partial in 29 (48%), and none in 13 (22%) patients. Reocclusion occurred in 34% of patients with any initial recanalization (16/47): in 4 of 16 patients with complete recanalization (22%), and in 12 of 29 patients with partial recanalization (41%). Reocclusion was detected in four patients (25%) before TPA bolus, in three (19%) by 30 minutes after bolus, in three (19%) by the end of infusion, and in six (37%) by 60 to 120 minutes. Before reocclusion, those patients had earlier median timing of recanalization: 130 versus 180 minutes after stroke onset compared with those who recanalized without reocclusion (p = 0.01). Median prebolus NIHSS score in the reocclusion group was 13.5 versus 17 (rest, NS), whereas at 2 and 24 hours, their NIHSS scores were higher: 14 versus 9 and 16 versus 6 points (p <= 0.04). Deterioration followed by improvement by >=4 NIHSS points occurred in 8 of 16 (50%) patients with reocclusion versus 10% (rest) (p < 0.05). In-hospital mortality was 25 versus 3% (p < 0.0001). At 3 months, good outcome (mRS score of 0 to 1) was achieved by 8% of patients with no recanalization, by 33% of patients with reocclusion, and by 50% of patients with stable recanalization (p <= 0.05), and mortality was 42% with no early recanalization, 33% after reocclusion, and 8% in patients with stable recanalization (p <= 0.05).

Conclusions: Early reocclusion occurs in 34% of TPA-treated patients with any initial recanalization, accounting for two-thirds of deteriorations following improvement. Reocclusion occurs more often in patients with earlier and partial recanalization, leading to neurologic deterioration and higher in-hospital mortality. However, patients with reocclusion have better long-term outcomes than patients without any early recanalization.




This article has been cited by other articles:


Home page
 StrokeHome page
A. V. Alexandrov, H. T. Nguyen, M. Rubiera, A. W. Alexandrov, L. Zhao, I. Heliopoulos, A. Robinson, J. DeWolfe, and G. Tsivgoulis
Prevalence and Risk Factors Associated With Reversed Robin Hood Syndrome in Acute Ischemic Stroke
Stroke, August 1, 2009; 40(8): 2738 - 2742.
[Abstract] [Full Text] [PDF]

Home page
 Journal of NeuroInterventional SurgeryHome page
R Novakovic, G Toth, and P D Purdy
Review of current and emerging therapies in acute ischemic stroke
JNIS, July 1, 2009; 1(1): 13 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
R.G. Nogueira, L.H. Schwamm, and J.A. Hirsch
Endovascular Approaches to Acute Stroke, Part 1: Drugs, Devices, and Data
AJNR Am. J. Neuroradiol., April 1, 2009; 30(4): 649 - 661.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Mikulik, D. Goldemund, M. Reif, P. Aulicky, and P. Krupa
Outcome of Patients With Negative CT Angiography Results for Arterial Occlusion Treated With Intravenous Thrombolysis
Stroke, March 1, 2009; 40(3): 868 - 872.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. M. Pancioli
Combination Pharmacotherapy for Achievement and Maintenance of Vascular Patency
Stroke, March 1, 2009; 40(3_suppl_1): S99 - S102.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. M. Pancioli, J. Broderick, T. Brott, T. Tomsick, J. Khoury, J. Bean, G. del Zoppo, D. Kleindorfer, D. Woo, P. Khatri, et al.
The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke: The CLEAR Stroke Trial
Stroke, December 1, 2008; 39(12): 3268 - 3276.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. Stolz, F. Cioli, J. Allendoerfer, T. Gerriets, M. Del Sette, and M. Kaps
Can Early Neurosonology Predict Outcome in Acute Stroke?: A Metaanalysis of Prognostic Clinical Effect Sizes Related to the Vascular Status
Stroke, December 1, 2008; 39(12): 3255 - 3261.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. Lyden
Thrombolytic Therapy for Acute Stroke -- Not a Moment to Lose
N. Engl. J. Med., September 25, 2008; 359(13): 1393 - 1395.
[Full Text] [PDF]

Home page
 StrokeHome page
J.-M. Olivot, M. Mlynash, V. N. Thijs, S. Kemp, M. G. Lansberg, L. Wechsler, G. Schlaug, R. Bammer, M. P. Marks, and G. W. Albers
Relationships Between Infarct Growth, Clinical Outcome, and Early Recanalization in Diffusion and Perfusion Imaging for Understanding Stroke Evolution (DEFUSE)
Stroke, August 1, 2008; 39(8): 2257 - 2263.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
B Thanvi, S Treadwell, and T Robinson
Early neurological deterioration in acute ischaemic stroke: predictors, mechanisms and management
Postgrad. Med. J., August 1, 2008; 84(994): 412 - 417.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. Sugiura, K. Iwaisako, S. Toyota, and H. Takimoto
Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset
AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1061 - 1066.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
H. Hallevi and J. C. Grotta
Antiplatelet Therapy and the Risk of Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
Arch Neurol, May 1, 2008; 65(5): 575 - 576.
[Full Text] [PDF]

Home page
 StrokeHome page
H.-P. Park, A. Nimmagadda, R. A. DeFazio, R. Busto, R. Prado, and M. D. Ginsberg
Albumin Therapy Augments the Effect of Thrombolysis on Local Vascular Dynamics in a Rat Model of Arteriolar Thrombosis: A Two-Photon Laser-Scanning Microscopy Study
Stroke, May 1, 2008; 39(5): 1556 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M.-F. Ritz, P. Ratajczak, Y. Curin, E. Cam, A. Mendelowitsch, F. Pinet, and R. Andriantsitohaina
Chronic Treatment with Red Wine Polyphenol Compounds Mediates Neuroprotection in a Rat Model of Ischemic Cerebral Stroke
J. Nutr., March 1, 2008; 138(3): 519 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
N. Janjua, A. Alkawi, M.F.K. Suri, and A.I. Qureshi
Impact of Arterial Reocclusion and Distal Fragmentation during Thrombolysis among Patients with Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 253 - 258.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
J. Marti-Fabregas, M. Borrell, D. Cocho, S. Martinez-Ramirez, M. Martinez-Corral, J. Fontcuberta, and J.-L. Marti-Vilalta
Change in Hemostatic Markers After Recombinant Tissue-Type Plasminogen Activator Is Not Associated With the Chance of Recanalization
Stroke, January 1, 2008; 39(1): 234 - 236.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. V. Alexandrov, V. K. Sharma, A. Y. Lao, G. Tsivgoulis, M. D. Malkoff, and A. W. Alexandrov
Reversed Robin Hood Syndrome in Acute Ischemic Stroke Patients
Stroke, November 1, 2007; 38(11): 3045 - 3048.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
L. B. Goldstein
Acute Ischemic Stroke Treatment in 2007
Circulation, September 25, 2007; 116(13): 1504 - 1514.
[Full Text] [PDF]

Home page
 CirculationHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
Circulation, May 22, 2007; 115(20): e478 - e534.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. P. Adams Jr, G. del Zoppo, M. J. Alberts, D. L. Bhatt, L. Brass, A. Furlan, R. L. Grubb, R. T. Higashida, E. C. Jauch, C. Kidwell, et al.
Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
Stroke, May 1, 2007; 38(5): 1655 - 1711.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
T. Tomsick
TIMI, TIBI, TICI: I Came, I Saw, I Got Confused
AJNR Am. J. Neuroradiol., February 1, 2007; 28(2): 382 - 384.
[Full Text] [PDF]

Home page
 StrokeHome page
H. M. Shaltoni, K. C. Albright, N. R. Gonzales, R. U. Weir, A. M. Khaja, R. M. Sugg, M. S. Campbell III, E. D. Cacayorin, J. C. Grotta, and E. A. Noser
Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke?
Stroke, January 1, 2007; 38(1): 80 - 84.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Saqqur, C. A. Molina, A. Salam, M. Siddiqui, M. Ribo, K. Uchino, S. Calleja, Z. Garami, K. Khan, N. Akhtar, et al.
Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study
Stroke, January 1, 2007; 38(1): 69 - 74.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. M. Kent, H. P. Selker, R. Ruthazer, E. Bluhmki, and W. Hacke
The Stroke-Thrombolytic Predictive Instrument: A Predictive Instrument for Intravenous Thrombolysis in Acute Ischemic Stroke
Stroke, December 1, 2006; 37(12): 2957 - 2962.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
R. M. Sugg, J. K. Pary, K. Uchino, S. Baraniuk, H. M. Shaltoni, N. R. Gonzales, R. Mikulik, Z. Garami, S. G. Shaw, D. E. Matherne, et al.
Argatroban tPA Stroke Study: Study Design and Results in the First Treated Cohort.
Arch Neurol, August 1, 2006; 63(8): 1057 - 1062.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. Tanne, R. F. Macko, Y. Lin, B. C. Tilley, S. R. Levine, and for the NINDS rtPA Stroke Study Group
Hemostatic Activation and Outcome After Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke
Stroke, July 1, 2006; 37(7): 1798 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
W.S. Smith and for the Multi MERCI Investigators
Safety of Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator in Acute Ischemic Stroke. Results of the Multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Trial, Part I
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1177 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 Emerg. Med. J.Home page
C-C Lai and C-J Hu
A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke
Emerg. Med. J., February 1, 2006; 23(2): e11 - e11.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
S. Mangiafico, M. Cellerini, P. Nencini, G. Gensini, and D. Inzitari
Intravenous Glycoprotein IIb/IIIa Inhibitor (Tirofiban) followed by Intra-Arterial Urokinase and Mechanical Thrombolysis in Stroke
AJNR Am. J. Neuroradiol., November 1, 2005; 26(10): 2595 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
P. Khatri, J. Neff, J. P. Broderick, J. C. Khoury, J. Carrozzella, T. Tomsick, and for the IMS-I Investigators
Revascularization End Points in Stroke Interventional Trials: Recanalization Versus Reperfusion in IMS-I
Stroke, November 1, 2005; 36(11): 2400 - 2403.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. Mangiafico, M. Cellerini, P. Nencini, G. Gensini, and D. Inzitari
Intravenous Tirofiban With Intra-Arterial Urokinase and Mechanical Thrombolysis in Stroke: Preliminary Experience in 11 Cases
Stroke, October 1, 2005; 36(10): 2154 - 2158.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J. Marti-Fabregas, M. Borrell, D. Cocho, R. Belvis, M. Castellanos, J. Montaner, J. Pagonabarraga, A. Aleu, L. Molina-Porcel, J. Diaz-Manera, et al.
Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA
Neurology, August 9, 2005; 65(3): 366 - 370.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
D. M. Kent, M. D. Hill, R. Ruthazer, S. B. Coutts, A. M. Demchuk, I. Dzialowski, O. Wunderlich, and R. von Kummer
"Clinical-CT Mismatch" and the Response to Systemic Thrombolytic Therapy in Acute Ischemic Stroke
Stroke, August 1, 2005; 36(8): 1695 - 1699.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
M. Rubiera, J. Alvarez-Sabin, M. Ribo, J. Montaner, E. Santamarina, J. F. Arenillas, R. Huertas, P. Delgado, F. Purroy, and C. A. Molina
Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
Stroke, July 1, 2005; 36(7): 1452 - 1456.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
H. Adams, R. Adams, G. Del Zoppo, and L. B. Goldstein
Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association
Stroke, April 1, 2005; 36(4): 916 - 923.
[Full Text] [PDF]

Home page
 StrokeHome page
Abciximab Emergent Stroke Treatment Trial Investi
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of a Randomized Phase 2 Trial
Stroke, April 1, 2005; 36(4): 880 - 890.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
E. A. Noser, H. M. Shaltoni, C. E. Hall, A. V. Alexandrov, Z. Garami, E. D. Cacayorin, J. K. Song, J. C. Grotta, and M. S. Campbell III
Aggressive Mechanical Clot Disruption: A Safe Adjunct to Thrombolytic Therapy in Acute Stroke?
Stroke, February 1, 2005; 36(2): 292 - 296.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. V. Alexandrov, C. A. Molina, J. C. Grotta, Z. Garami, S. R. Ford, J. Alvarez-Sabin, J. Montaner, M. Saqqur, A. M. Demchuk, L. A. Moye, et al.
Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke
N. Engl. J. Med., November 18, 2004; 351(21): 2170 - 2178.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. V. Alexandrov
Ultrasound Identification and Lysis of Clots
Stroke, November 1, 2004; 35(11_suppl_1): 2722 - 2725.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
K. Y. Lee, D. I. Kim, S. H. Kim, S. I. Lee, H. W. Chung, Y. W. Shim, S. M. Kim, and J. H. Heo
Sequential Combination of Intravenous Recombinant Tissue Plasminogen Activator and Intra-Arterial Urokinase in Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1470 - 1475.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
R. Leigh, O. O. Zaidat, M. F. Suri, G. Lynch, S. Sundararajan, J. L. Sunshine, R. Tarr, W. Selman, D. M.D. Landis, and J. I. Suarez
Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy
Stroke, August 1, 2004; 35(8): 1903 - 1907.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. A. Sloan, A. V. Alexandrov, C. H. Tegeler, M. P. Spencer, L. R. Caplan, E. Feldmann, L. R. Wechsler, D. W. Newell, C. R. Gomez, V. L. Babikian, et al.
Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, May 11, 2004; 62(9): 1468 - 1481.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
S. E. Kasner
Editorial Comment--More Than One Way to Lyse a Clot
Stroke, April 1, 2004; 35(4): 911 - 912.
[Full Text] [PDF]

Home page
 StrokeHome page
S. Straub, U. Junghans, V. Jovanovic, H. J. Wittsack, R. J. Seitz, and M. Siebler
Systemic Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Acute Middle Cerebral Artery Occlusion
Stroke, March 1, 2004; 35(3): 705 - 709.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
A. I. Qureshi, A. M. Siddiqui, S. H. Kim, R. A. Hanel, A. R. Xavier, J. F. Kirmani, M. F. K. Suri, A. S. Boulos, and L. N. Hopkins
Reocclusion of Recanalized Arteries during Intra-arterial Thrombolysis for Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 322 - 328.
[Abstract] [Full Text] [PDF]

Home page
 StrokeHome page
A. V. Alexandrov, C. E. Hall, L. A. Labiche, A. W. Wojner, and J. C. Grotta
Ischemic Stunning of the Brain: Early Recanalization Without Immediate Clinical Improvement in Acute Ischemic Stroke
Stroke, February 1, 2004; 35(2): 449 - 452.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
J. C. Grotta
Adding to the Effectiveness of Intravenous Tissue Plasminogen Activator for Treating Acute Stroke
Circulation, June 10, 2003; 107(22): 2769 - 2770.
[Full Text] [PDF]

Home page
 StrokeHome page
S. Warach
Stroke Neuroimaging
Stroke, February 1, 2003; 34(2): 345 - 347.
[Full Text] [PDF]

Home page
 JWatch Emergency Med.Home page
Reocclusion After Thrombolysis in Stroke Patients
Journal Watch Emergency Medicine, November 26, 2002; 2002(1126): 3 - 3.
[Full Text]

Home page
 JWatch NeurologyHome page
Ultrasound-Detected Reocclusion Common After IV TPA for Stroke
Journal Watch Neurology, November 8, 2002; 2002(1108): 2 - 2.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by AAN Enterprises, Inc.